Your browser doesn't support javascript.
loading
Synthesis of 2'-modified N6-methyladenosine phosphoramidites and their incorporation into siRNA.
Rydzik, Anna M; Riether, Doris; Gottschling, Dirk.
Affiliation
  • Rydzik AM; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany. Electronic address: anna.rydzik@astrazeneca.com.
  • Riether D; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
  • Gottschling D; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
Bioorg Med Chem Lett ; 81: 129126, 2023 02 01.
Article in En | MEDLINE | ID: mdl-36632927
A synthesis of 2'-fluoro and 2'-methoxy N6-methyladenosine phosphoramidites and their successful incorporation into oligonucleotides is reported. 2'-fluoro and 2́-methoxy modifications of sugars in siRNAs are known to aid stability and N6-methylation modifies the potency of therapeutic silencing RNAs (siRNA). We demonstrate that a combination of those modifications incorporated into the antisense strand of siRNA leads to efficient knockdown of a target gene in cells. This work broadens the available pool of chemical modifications of therapeutic siRNAs and provides tools for their efficient synthesis.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organophosphorus Compounds Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2023 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organophosphorus Compounds Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2023 Document type: Article Country of publication: United kingdom